The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study
Open accessPublished version of a preprint
Abstract
Objective: To understand the epidemiology and burden of severe coronavirus disease 2019 (covid-19) during the first epidemic wave on the west coast of the United States. Design: Prospective cohort study. Setting: Kaiser Permanente integrated healthcare delivery systems serving populations in northern California, southern California, and Washington state. Participants: 1840 people with a first acute hospital admission for confirmed covid-19 by 22 April 2020, among 9 596 321 healthcare plan enrollees. Analyses of hospital length of stay and clinical outcomes included 1328 people admitted by 9 April 2020 (534 in northern California, 711 in southern California, and 83 in Washington). Main outcome measures: Cumulative incidence of first acute hospital admission for confirmed covid-19, and subsequent probabilities of admission to an intensive care unit (ICU) and mortality, as well as duration of hospital stay and ICU stay. The effective reproduction number ( R E ) describing transmission dynamics was estimated for each region. Results: As of 22 April 2020, cumulative incidences of a first acute hospital admission for covid-19 were 15.6 per 100 000 cohort members in northern California, 23.3 per 100 000 in southern California, and 14.7 per 100 000 in Washington. Accounting for censoring of incomplete hospital stays among those admitted by 9 April 2020, the estimated median duration of stay among survivors was 9.3 days (with 95% staying 0.8 to 32.9 days) and among non-survivors was 12.7 days (1.6 to 37.7 days). The censoring adjusted probability of ICU admission for male patients was 48.5% (95% confidence interval 41.8% to 56.3%) and for female patients was 32.0% (26.6% to 38.4%). For patients requiring critical care, the median duration of ICU stay was 10.6 days (with 95% staying 1.3 to 30.8 days). The censoring adjusted case fatality ratio was 23.5% (95% confidence interval 19.6% to 28.2%) among male inpatients and 14.9% (11.8% to 18.6%) among female inpatients; mortality risk increased with age for both male and female patients. Reductions in R E were identified over the study period within each region. Conclusions: Among residents of California and Washington state enrolled in Kaiser Permanente healthcare plans who were admitted to hospital with covid-19, the probabilities of ICU admission, of long hospital stay, and of mortality were identified to be high. Incidence rates of new hospital admissions have stabilized or declined in conjunction with implementation of social distancing interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., et al. (2020) · JAMA · doi:10.1001/jama.2020.5394 · Cited by 5,469
Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171
COVID-19 and Italy: what next?
Remuzzi, A., & Remuzzi, G. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30627-9 · Cited by 3,119
Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State
Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020) · JAMA · doi:10.1001/jama.2020.4326 · Cited by 2,259
Estimating the burden of SARS-CoV-2 in France
Salje, H., Tran Kiem, C., Lefrancq, N., Courtejoie, N., Bosetti, P., Paireau, J., Andronico, A., Hozé, N., Richet, J., Dubost, C.-L., et al. (2020) · Science · doi:10.1126/science.abc3517 · Cited by 1,038
Myers, L. C., Parodi, S. M., Escobar, G. J., & Liu, V. X. (2020) · JAMA · doi:10.1001/jama.2020.7202 · Cited by 467
Self-citationQian, G. Q., Yang, N. B., Ding, F., Ma, A. H. Y., Wang, Z. Y., Shen, Y. F., Shi, C. W., Lian, X., Chu, J. G., Chen, L., et al. (2020) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hcaa089 · Cited by 382
Research works printed but not linked: 31
- 10.1136/bmj.m1090 · DOI · Paper page
- 10.1016/j.cmi.2020.02.005 · DOI
- 10.25561/77482 · doi:10.25561/77482 · Paper page
- 10.1016/S0140-6736(20)30743-1 · doi:10.1016/s0140-6736(20)30743-1
- 10.7812/TPP/12-031 · DOI · Paper page
- Saunders KW Davis RL Stergachis A . Group health cooperative. Pharmacoepidemiology, 2006: 223-39. · DOI
- 10.7812/TPP/18-091 · DOI
- 10.18637/jss.v089.i09 · doi:10.18637/jss.v089.i09
- 10.1093/aje/kwh255 · DOI · Paper page
- 10.1101/2020.03.03.20029983 · DOI
- 10.2807/1560-7917.ES.2020.25.5.2000062 · DOI · Paper page
- 10.3390/jcm9020538 · DOI · Paper page
- 10.1016/S1473-3099(20)30230-9 · DOI · Paper page
- 10.1001/jama.2020.1585 · DOI · Paper page
- 10.1016/S1473-3099(20)30243-7 · DOI · Paper page
- 10.1101/2020.04.20.20072413 · doi:10.1101/2020.04.20.20072413
- 10.3201/eid2606.200357 · DOI · Paper page
- 10.1016/j.ijid.2020.02.060 · DOI · Paper page
- 10.15585/mmwr.mm6915e2 · DOI · Paper page
- 10.1101/2020.04.08.20057794 · DOI
- 10.7812/TPP/15-225 · DOI · Paper page
- 10.1001/jama.2020.6585 · DOI · Paper page
- 10.7326/M20-1565 · DOI
- 10.1016/S0140-6736(20)30566-3 · DOI · Paper page
- 10.1101/2020.03.09.20033241 · DOI
- 10.1101/2020.04.05.20054528 · doi:10.1101/2020.04.05.20054528
- 10.1503/cmaj.200476 · DOI · Paper page
- 10.1097/CM9.0000000000000744 · DOI · Paper page
- 10.1056/NEJMoa2002032 · DOI · Paper page
- 10.1001/jama.2020.2648 · DOI · Paper page
- 10.1016/S1473-3099(20)30190-0 · DOI · Paper page
Cited by
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
The ATTACC, A.-4. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2105911 · Cited by 1,046
COVID-19 length of hospital stay: a systematic review and data synthesis
Rees, E. M., Nightingale, E. S., Jafari, Y., Waterlow, N. R., Clifford, S., B. Pearson, C. A., Group, C. W., Jombart, T., Procter, S. R., & Knight, G. M. (2020) · BMC Medicine · doi:10.1186/s12916-020-01726-3 · Cited by 655
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
ATTACC Investigators, ACTIV-4a Investigators, REMAP-CAP Investigators, Lawler, P. R., Goligher, E. C., Berger, J. S., Neal, M. D., McVerry, B. J., Nicolau, J. C., Gong, M. N., et al. (n.d.) · Bern Open Repository and Information System (University of Bern) · doi:10.17863/cam.76384 · Cited by 581
Epidemiology and transmission dynamics of COVID-19 in two Indian states
Laxminarayan, R., Wahl, B., Dudala, S. R., Gopal, K., Mohan B, C., Neelima, S., Jawahar Reddy, K. S., Radhakrishnan, J., & Lewnard, J. A. (2020) · Science · doi:10.1126/science.abd7672 · Cited by 485
Self-citationRouzé, A., Martin-Loeches, I., Povoa, P., Makris, D., Artigas, A., Bouchereau, M., Lambiotte, F., Metzelard, M., Cuchet, P., Boulle Geronimi, C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-020-06323-9 · Cited by 382
Metadata
- Authors
- Lewnard, J. A., Liu, V. X., Jackson, M. L., Schmidt, M. A., Jewell, B. L., Flores, J. P., Jentz, C., Northrup, G. R., Mahmud, A., Reingold, A. L., Petersen, M., Jewell, N. P., Young, S., & Bellows, J.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2020-05-22
- Volume
- 369
- Pages
- m1923
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W3027770179
- Cited by
- 212
- References
- 10
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-06-04)
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study. https://app.cochat.ai/papers/10.1136/bmj.m1923
- The paper
- Lewnard, J. A., Liu, V. X., Jackson, M. L., Schmidt, M. A., Jewell, B. L., Flores, J. P., Jentz, C., Northrup, G. R., Mahmud, A., Reingold, A. L., Petersen, M., Jewell, N. P., Young, S., & Bellows, J. (2020). Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study. BMJ. https://doi.org/10.1136/bmj.m1923
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.